サインイン 無料でサインアップします。

Last updated: 2 March 2023 at 7:30pm EST

John Capek Net Worth




The estimated Net Worth of John M Capek is at least 60.9 百万$ dollars as of 13 December 2021. John Capek owns over 149,600 units of Abbott Laboratories stock worth over 54,918,367$ and over the last 18 years he sold ABT stock worth over 2,229,574$. In addition, he makes 3,765,920$ as Executive Vice President - Ventures at Abbott Laboratories.

John Capek ABT stock SEC Form 4 insiders trading

John has made over 12 trades of the Abbott Laboratories stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 149,600 units of ABT stock worth 5,227,024$ on 13 December 2021.

The largest trade he's ever made was exercising 149,600 units of Abbott Laboratories stock on 13 December 2021 worth over 5,227,024$. On average, John trades about 16,414 units every 73 days since 2007. As of 13 December 2021 he still owns at least 470,998 units of Abbott Laboratories stock.

You can see the complete history of John Capek stock trades at the bottom of the page.





John Capek biography

Dr. John M. Capek Ph.D. serves as Executive Vice President - Ventures of the Company. was Executive Vice President - Ventures of the Company. Previously, he served as Senior Vice President, Abbott Vascular, heading up Abbott's global vascular business. Dr. Capek served in various management roles at Guidant, including president, Guidant Vascular Intervention and Vice President and General Manager of Bioabsorbable Vascular Solutions. He also served as Vice President and General Manager of Guidant Germany and Vice President, Marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Dr. Capek was manager of New Product Technology at Eli Lilly & Company. Dr. Capek has a Bachelor's degree in Biomedical Engineering, a Master's degree in Biomedical Engineering, a Master's degree in Electrical Engineering, a Ph.D. in Biomedical Engineering and a Master's degree in Business Administration from Rensselaer Polytechnic Institute.

What is the salary of John Capek?

As the Executive Vice President - Ventures of Abbott Laboratories, the total compensation of John Capek at Abbott Laboratories is 3,765,920$. There are 7 executives at Abbott Laboratories getting paid more, with Miles White having the highest compensation of 27,802,800$.



How old is John Capek?

John Capek is 58, he's been the Executive Vice President - Ventures of Abbott Laboratories since 2015. There are 21 older and 17 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 75, who is the Independent Director.

What's John Capek's mailing address?

John's mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064.

Insiders trading at Abbott Laboratories

Over the last 24 years, insiders at Abbott Laboratories have traded over 388,257,551$ worth of Abbott Laboratories stock and bought 1,028,477 units worth 44,923,618$ . The most active insiders traders include Miles D White、Richard A Gonzalez、Jeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of 4,003,344$. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth 3,100$.



What does Abbott Laboratories do?

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.



What does Abbott Laboratories's logo look like?

Abbott Laboratories logo

Complete history of John Capek stock trades at Abbott Laboratories

日付
#
会社
 インサイダー
取引
取引
 株式 1株当たりの株価 合計金額 その後の株式数 ソース
13 Dec 2021 ABT Abbott Laboratories John M Capek
副社長
 オプション行使 149,600 34.94$ 5,227,024$
13 Dec 2021
470,998 ↗
27 Aug 2020 ABT Abbott Laboratories John M Capek
副社長
 オプション行使 52,300 27.03$ 1,413,669$
27 Aug 2020
369,100 ↗
21 Apr 2020 ABT Abbott Laboratories John M Capek
副社長
 オプション行使 50,100 22.39$ 1,121,739$
21 Apr 2020
366,900 ↗
20 Jun 2019 ABT Abbott Laboratories John M Capek
副社長
 オプション行使 46,900 26.19$ 1,228,311$
20 Jun 2019
355,435 ↗
25 Jul 2018 ABT Abbott Laboratories John M Capek
副社長
 オプション行使 64,900 26.02$ 1,688,698$
25 Jul 2018
363,200 ↗
17 Feb 2017 ABT Abbott Laboratories John M Capek
副社長
 オプション行使 93,400 26.70$ 2,493,780$
17 Feb 2017
382,197 ↗
17 Feb 2017 ABT Abbott Laboratories John M Capek
副社長
 オプション行使 93,400 26.70$ 2,493,780$
17 Feb 2017
382,197 ↗
16 Nov 2016 ABT Abbott Laboratories John M Capek
副社長
 オプション行使 22,000 24.38$ 536,360$
16 Nov 2016
274,524 ↗
4 Feb 2015 ABT Abbott Laboratories John M Capek
副社長
 販売 9,935 45.83$ 455,321$
4 Feb 2015
226,945 ↗
4 Feb 2015 ABT Abbott Laboratories John M Capek
副社長
 販売 38,773 45.76$ 1,774,252$
4 Feb 2015
236,880 ↗
4 Feb 2015 ABT Abbott Laboratories John M Capek
副社長
 オプション行使 83,000 25.25$ 2,095,750$
4 Feb 2015
309,945 ↗
5 Mar 2012 ABT Abbott Laboratories John M Capek
副社長
 オプション行使 100,000 41.92$ 4,192,000$
5 Mar 2012
315,551 ↗


Abbott Laboratories executives and stock owners

Abbott Laboratories executives and other stock owners filed with the SEC include: